chr6-52058640-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_138694.4(PKHD1):c.1234-39C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00351 in 1,594,556 control chromosomes in the GnomAD database, including 169 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.019 ( 91 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 78 hom. )
Consequence
PKHD1
NM_138694.4 intron
NM_138694.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.308
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 6-52058640-G-C is Benign according to our data. Variant chr6-52058640-G-C is described in ClinVar as [Benign]. Clinvar id is 262387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0637 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0189 AC: 2872AN: 152166Hom.: 90 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2872
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00478 AC: 1170AN: 244552 AF XY: 0.00339 show subpopulations
GnomAD2 exomes
AF:
AC:
1170
AN:
244552
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00189 AC: 2726AN: 1442272Hom.: 78 Cov.: 28 AF XY: 0.00169 AC XY: 1217AN XY: 718688 show subpopulations
GnomAD4 exome
AF:
AC:
2726
AN:
1442272
Hom.:
Cov.:
28
AF XY:
AC XY:
1217
AN XY:
718688
Gnomad4 AFR exome
AF:
AC:
2208
AN:
33164
Gnomad4 AMR exome
AF:
AC:
169
AN:
44708
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26050
Gnomad4 EAS exome
AF:
AC:
0
AN:
39626
Gnomad4 SAS exome
AF:
AC:
9
AN:
85926
Gnomad4 FIN exome
AF:
AC:
0
AN:
50038
Gnomad4 NFE exome
AF:
AC:
85
AN:
1097198
Gnomad4 Remaining exome
AF:
AC:
242
AN:
59830
Heterozygous variant carriers
0
144
289
433
578
722
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0189 AC: 2877AN: 152284Hom.: 91 Cov.: 32 AF XY: 0.0182 AC XY: 1353AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
2877
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
1353
AN XY:
74472
Gnomad4 AFR
AF:
AC:
0.0657952
AN:
0.0657952
Gnomad4 AMR
AF:
AC:
0.0073193
AN:
0.0073193
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000161708
AN:
0.000161708
Gnomad4 OTH
AF:
AC:
0.00948767
AN:
0.00948767
Heterozygous variant carriers
0
137
274
410
547
684
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal recessive polycystic kidney disease Benign:1
Apr 13, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at